MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617095796 A) filed by Universitat De Barcelona; Fundaci De Recerca Clnic Barcelona-Institut; and Hospital Clinic De Barcelona on August 07, 2026, for Interleukin-13 Receptor Subunit Alpha-2 (il13ralpha2) Targeting Moieties For The Treatment And Prevention Of Il13ralpha2-Positive Cancer.
Inventors include Ortiz De Landazuri Pascal, Iaki; Juan Otero, Manuel; Uribe Herranz, Mireia; Casanovas Albert, Berta; Vazquez Portero, Mario; Engel Rocamora, Pablo; and Martnez Soler, Roberto.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The present invention provides Interleukin-13 Receptor Subunit Alpha-2 (...